Positive response of a recurrent clear cell sarcoma to anlotinib combined with chemotherapy: A case report

Renal clear cell sarcoma is a rare and highly invasive malignant renal tumor that easily relapses after treatment. Recurrent recurrent clear cell carcinoma (CCSK) responds poorly to chemotherapy and has no established standardized treatment, and need to be explored potentially useful treatments. PAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Junyue, Yang, Hao, Hao, Zongyao, Liang, Chaozhao, Du, Yingying, Zhang, Chao, Yin, Yu, Zhou, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
7300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726286/
https://www.ncbi.nlm.nih.gov/pubmed/36482604
http://dx.doi.org/10.1097/MD.0000000000032109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726286/
https://www.ncbi.nlm.nih.gov/pubmed/36482604
http://dx.doi.org/10.1097/MD.0000000000032109

Ejemplares similares